Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adrenal Gland Neoplasms | 23 | 2024 | 740 | 4.970 |
Why?
|
Adrenal Gland Diseases | 10 | 2020 | 138 | 3.780 |
Why?
|
Tomography, X-Ray Computed | 85 | 2023 | 20129 | 2.980 |
Why?
|
Incidental Findings | 14 | 2021 | 689 | 2.520 |
Why?
|
Catheter Ablation | 25 | 2015 | 2758 | 2.070 |
Why?
|
Radiology | 16 | 2022 | 2100 | 1.670 |
Why?
|
Radiation Protection | 4 | 2018 | 419 | 1.660 |
Why?
|
Diagnostic Imaging | 14 | 2021 | 3507 | 1.660 |
Why?
|
Radiography, Interventional | 10 | 2016 | 1095 | 1.260 |
Why?
|
Radiography, Abdominal | 8 | 2016 | 537 | 1.060 |
Why?
|
Kidney Neoplasms | 14 | 2018 | 4262 | 1.050 |
Why?
|
Radiation Dosage | 8 | 2016 | 1928 | 1.050 |
Why?
|
Adenoma | 7 | 2023 | 2174 | 1.000 |
Why?
|
Contrast Media | 30 | 2023 | 5300 | 0.920 |
Why?
|
Abdominal Pain | 6 | 2012 | 1063 | 0.920 |
Why?
|
Myelolipoma | 1 | 2023 | 12 | 0.910 |
Why?
|
Surgery, Computer-Assisted | 6 | 2013 | 1018 | 0.900 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2015 | 1184 | 0.840 |
Why?
|
Adrenocortical Adenoma | 4 | 2023 | 48 | 0.770 |
Why?
|
Societies, Medical | 6 | 2021 | 3743 | 0.770 |
Why?
|
Urography | 2 | 2012 | 313 | 0.750 |
Why?
|
Body Burden | 2 | 2012 | 158 | 0.750 |
Why?
|
Hematuria | 2 | 2012 | 235 | 0.740 |
Why?
|
Ablation Techniques | 4 | 2018 | 249 | 0.730 |
Why?
|
Radiometry | 3 | 2015 | 800 | 0.730 |
Why?
|
Advisory Committees | 3 | 2018 | 775 | 0.660 |
Why?
|
Pheochromocytoma | 3 | 2014 | 337 | 0.640 |
Why?
|
Artifacts | 4 | 2013 | 1904 | 0.620 |
Why?
|
Sensitivity and Specificity | 28 | 2024 | 14722 | 0.570 |
Why?
|
Colonography, Computed Tomographic | 2 | 2015 | 169 | 0.560 |
Why?
|
Appendicitis | 3 | 2013 | 645 | 0.510 |
Why?
|
Carcinoma, Renal Cell | 7 | 2016 | 3143 | 0.490 |
Why?
|
Diagnosis, Differential | 22 | 2023 | 12959 | 0.480 |
Why?
|
Body Size | 2 | 2015 | 461 | 0.470 |
Why?
|
Adrenocortical Carcinoma | 1 | 2014 | 88 | 0.460 |
Why?
|
Lipoma | 2 | 2009 | 334 | 0.440 |
Why?
|
Humans | 166 | 2024 | 744343 | 0.440 |
Why?
|
Sigmoid Diseases | 1 | 2012 | 50 | 0.430 |
Why?
|
Iodine | 2 | 2016 | 286 | 0.430 |
Why?
|
Liver Neoplasms | 14 | 2013 | 4253 | 0.430 |
Why?
|
Pregnancy Complications | 4 | 2010 | 2861 | 0.430 |
Why?
|
Cryosurgery | 2 | 2008 | 453 | 0.410 |
Why?
|
Body Water | 1 | 2013 | 343 | 0.410 |
Why?
|
Foreign Bodies | 2 | 2012 | 399 | 0.390 |
Why?
|
Urinary Calculi | 1 | 2011 | 91 | 0.390 |
Why?
|
Barium Sulfate | 1 | 2011 | 180 | 0.380 |
Why?
|
Efficiency, Organizational | 2 | 2020 | 695 | 0.380 |
Why?
|
Models, Organizational | 1 | 2014 | 574 | 0.370 |
Why?
|
Aged, 80 and over | 42 | 2018 | 57776 | 0.370 |
Why?
|
Burns, Electric | 1 | 2010 | 42 | 0.360 |
Why?
|
Ultrasonography, Interventional | 4 | 2016 | 1486 | 0.360 |
Why?
|
Magnetic Resonance Imaging | 28 | 2023 | 35421 | 0.360 |
Why?
|
Radiography | 9 | 2020 | 7023 | 0.350 |
Why?
|
Aged | 69 | 2018 | 163280 | 0.350 |
Why?
|
Adult | 75 | 2018 | 214055 | 0.350 |
Why?
|
Workload | 2 | 2020 | 850 | 0.350 |
Why?
|
Pulmonary Embolism | 5 | 2011 | 2376 | 0.340 |
Why?
|
Workflow | 1 | 2014 | 847 | 0.340 |
Why?
|
Whole-Body Counting | 1 | 2009 | 35 | 0.340 |
Why?
|
Middle Aged | 74 | 2018 | 213383 | 0.340 |
Why?
|
Flank Pain | 1 | 2009 | 43 | 0.340 |
Why?
|
Lung Neoplasms | 14 | 2011 | 13102 | 0.340 |
Why?
|
Algorithms | 12 | 2018 | 13881 | 0.340 |
Why?
|
Adrenalectomy | 1 | 2011 | 341 | 0.340 |
Why?
|
Liver Diseases | 6 | 2009 | 1253 | 0.330 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2291 | 0.330 |
Why?
|
Gases | 3 | 2003 | 197 | 0.330 |
Why?
|
Hernia | 1 | 2008 | 71 | 0.330 |
Why?
|
Radiation Injuries | 2 | 2015 | 1180 | 0.330 |
Why?
|
Microwaves | 3 | 2008 | 191 | 0.320 |
Why?
|
Speech Recognition Software | 1 | 2008 | 72 | 0.320 |
Why?
|
Leadership | 1 | 2018 | 1357 | 0.320 |
Why?
|
Ultrasonography | 6 | 2014 | 5985 | 0.320 |
Why?
|
Mesentery | 1 | 2008 | 205 | 0.310 |
Why?
|
Biopsy | 9 | 2018 | 6756 | 0.310 |
Why?
|
Retrospective Studies | 40 | 2024 | 77449 | 0.310 |
Why?
|
Male | 87 | 2018 | 350118 | 0.310 |
Why?
|
Metals | 1 | 2012 | 719 | 0.300 |
Why?
|
Female | 94 | 2018 | 380194 | 0.300 |
Why?
|
Radiographic Image Enhancement | 2 | 2011 | 885 | 0.300 |
Why?
|
Fecal Impaction | 1 | 2007 | 34 | 0.300 |
Why?
|
Hepatic Duct, Common | 2 | 1999 | 50 | 0.300 |
Why?
|
Rhode Island | 6 | 2012 | 347 | 0.290 |
Why?
|
Bile Duct Neoplasms | 3 | 1999 | 567 | 0.290 |
Why?
|
Stomach Ulcer | 1 | 2007 | 125 | 0.290 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2009 | 426 | 0.290 |
Why?
|
Tomography, Spiral Computed | 3 | 2009 | 280 | 0.280 |
Why?
|
Observer Variation | 6 | 2013 | 2593 | 0.280 |
Why?
|
Decision Making | 2 | 2018 | 3887 | 0.270 |
Why?
|
Radiology Information Systems | 2 | 2008 | 523 | 0.260 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 274 | 0.260 |
Why?
|
Adrenal Glands | 3 | 2021 | 546 | 0.260 |
Why?
|
Bone Neoplasms | 4 | 2005 | 2529 | 0.260 |
Why?
|
Electrocoagulation | 1 | 2005 | 158 | 0.250 |
Why?
|
Equipment Failure | 1 | 2007 | 578 | 0.250 |
Why?
|
Cerebral Angiography | 4 | 2008 | 1285 | 0.250 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 868 | 0.250 |
Why?
|
Reproducibility of Results | 12 | 2017 | 19905 | 0.250 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2016 | 8949 | 0.240 |
Why?
|
Multi-Institutional Systems | 1 | 2003 | 43 | 0.240 |
Why?
|
Cholestasis | 2 | 1999 | 378 | 0.230 |
Why?
|
Image Enhancement | 5 | 2009 | 2921 | 0.230 |
Why?
|
Iohexol | 6 | 2011 | 196 | 0.230 |
Why?
|
User-Computer Interface | 2 | 2018 | 1431 | 0.230 |
Why?
|
Developing Countries | 2 | 2013 | 2815 | 0.230 |
Why?
|
Peritoneal Neoplasms | 1 | 2009 | 665 | 0.220 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2003 | 162 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2010 | 5221 | 0.220 |
Why?
|
Medical Records | 1 | 2008 | 1413 | 0.220 |
Why?
|
Angiomyolipoma | 2 | 2009 | 190 | 0.220 |
Why?
|
Brain Diseases | 2 | 2004 | 1563 | 0.220 |
Why?
|
Ultrasonography, Mammary | 1 | 2005 | 250 | 0.220 |
Why?
|
Periodicals as Topic | 1 | 2013 | 1432 | 0.210 |
Why?
|
Liver | 10 | 2009 | 7474 | 0.210 |
Why?
|
Angiography | 2 | 2008 | 1639 | 0.210 |
Why?
|
Embolization, Therapeutic | 1 | 2012 | 1392 | 0.210 |
Why?
|
Risk Management | 2 | 2016 | 571 | 0.210 |
Why?
|
Hemorrhage | 2 | 2016 | 3461 | 0.210 |
Why?
|
Computer Systems | 1 | 2003 | 483 | 0.210 |
Why?
|
Intestines | 1 | 2011 | 1924 | 0.200 |
Why?
|
Digestive System Diseases | 2 | 2003 | 147 | 0.200 |
Why?
|
Pacemaker, Artificial | 1 | 2007 | 816 | 0.200 |
Why?
|
Adenoma, Oxyphilic | 1 | 2003 | 143 | 0.200 |
Why?
|
Portal Vein | 3 | 2003 | 437 | 0.200 |
Why?
|
Databases as Topic | 1 | 2003 | 475 | 0.200 |
Why?
|
Breast Diseases | 1 | 2005 | 443 | 0.200 |
Why?
|
Jejunal Neoplasms | 1 | 2000 | 18 | 0.190 |
Why?
|
Pancreaticojejunostomy | 1 | 2000 | 26 | 0.190 |
Why?
|
Cecal Diseases | 1 | 2000 | 51 | 0.190 |
Why?
|
Teaching Materials | 1 | 2001 | 86 | 0.190 |
Why?
|
Internship and Residency | 2 | 2018 | 5788 | 0.190 |
Why?
|
Public Health | 2 | 2013 | 2603 | 0.190 |
Why?
|
Jejunal Diseases | 1 | 2000 | 50 | 0.180 |
Why?
|
Stents | 3 | 1999 | 3280 | 0.180 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 931 | 0.180 |
Why?
|
Pyelonephritis | 1 | 2000 | 75 | 0.180 |
Why?
|
Congresses as Topic | 3 | 2014 | 764 | 0.180 |
Why?
|
Gastric Bypass | 1 | 2008 | 812 | 0.180 |
Why?
|
Abdomen | 2 | 2017 | 1118 | 0.180 |
Why?
|
Treatment Outcome | 19 | 2018 | 63114 | 0.170 |
Why?
|
Neurocysticercosis | 1 | 2000 | 62 | 0.170 |
Why?
|
Pancreatic Ducts | 2 | 2000 | 328 | 0.170 |
Why?
|
Terminology as Topic | 2 | 2018 | 1547 | 0.170 |
Why?
|
Intussusception | 1 | 2000 | 115 | 0.170 |
Why?
|
Enteritis | 1 | 2000 | 165 | 0.170 |
Why?
|
Colorectal Neoplasms | 2 | 2010 | 6773 | 0.170 |
Why?
|
Pyridoxal Phosphate | 2 | 1998 | 127 | 0.170 |
Why?
|
Biopsy, Needle | 6 | 2009 | 1641 | 0.160 |
Why?
|
Spine | 3 | 2000 | 1144 | 0.160 |
Why?
|
Edetic Acid | 2 | 1998 | 276 | 0.160 |
Why?
|
Equipment Design | 4 | 2015 | 3582 | 0.160 |
Why?
|
Crohn Disease | 1 | 2011 | 2303 | 0.160 |
Why?
|
Computers | 1 | 2001 | 612 | 0.160 |
Why?
|
Forecasting | 2 | 2018 | 2951 | 0.160 |
Why?
|
Teratoma | 1 | 2001 | 395 | 0.160 |
Why?
|
Palliative Care | 4 | 2007 | 3493 | 0.150 |
Why?
|
Radiology Department, Hospital | 1 | 2002 | 412 | 0.150 |
Why?
|
Genital Diseases, Female | 1 | 1999 | 197 | 0.150 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1333 | 0.150 |
Why?
|
Emphysema | 1 | 2000 | 247 | 0.150 |
Why?
|
Oxides | 2 | 1996 | 405 | 0.150 |
Why?
|
Cushing Syndrome | 2 | 1989 | 249 | 0.150 |
Why?
|
Radioisotope Teletherapy | 1 | 1996 | 18 | 0.140 |
Why?
|
Environmental Exposure | 1 | 2011 | 4234 | 0.140 |
Why?
|
Iridium Radioisotopes | 1 | 1996 | 26 | 0.140 |
Why?
|
Cobalt Radioisotopes | 1 | 1996 | 76 | 0.140 |
Why?
|
Electronic Mail | 1 | 2018 | 213 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 251 | 0.140 |
Why?
|
Nephrectomy | 2 | 2012 | 1050 | 0.140 |
Why?
|
Risk Assessment | 7 | 2018 | 23338 | 0.140 |
Why?
|
Diatrizoate Meglumine | 1 | 2015 | 83 | 0.130 |
Why?
|
Unnecessary Procedures | 2 | 2018 | 432 | 0.130 |
Why?
|
Brachytherapy | 2 | 2010 | 1248 | 0.130 |
Why?
|
Uncertainty | 2 | 2018 | 734 | 0.130 |
Why?
|
Education, Medical | 2 | 2013 | 1721 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 1 | 2000 | 933 | 0.130 |
Why?
|
Positron-Emission Tomography | 4 | 2014 | 6234 | 0.130 |
Why?
|
Patient Selection | 3 | 2013 | 4215 | 0.130 |
Why?
|
Pregnancy | 6 | 2010 | 29144 | 0.130 |
Why?
|
Catheterization | 1 | 2000 | 1470 | 0.130 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15076 | 0.130 |
Why?
|
Kidney Calculi | 1 | 1999 | 465 | 0.120 |
Why?
|
Drainage | 3 | 2016 | 1142 | 0.120 |
Why?
|
Equipment Safety | 1 | 2015 | 264 | 0.120 |
Why?
|
Pancreatitis | 2 | 2002 | 1092 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1170 | 0.120 |
Why?
|
Software | 2 | 2015 | 4443 | 0.120 |
Why?
|
Cerebrovascular Circulation | 1 | 2004 | 2731 | 0.120 |
Why?
|
Deglutition | 2 | 2012 | 197 | 0.120 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2015 | 876 | 0.120 |
Why?
|
Scoliosis | 1 | 2000 | 725 | 0.110 |
Why?
|
Pulmonary Artery | 3 | 2011 | 1912 | 0.110 |
Why?
|
Cooking and Eating Utensils | 1 | 2012 | 3 | 0.110 |
Why?
|
Teleradiology | 1 | 2013 | 53 | 0.110 |
Why?
|
Blood Coagulation Disorders | 1 | 2016 | 337 | 0.110 |
Why?
|
Fluoroscopy | 3 | 2012 | 924 | 0.110 |
Why?
|
Adolescent | 19 | 2012 | 85781 | 0.110 |
Why?
|
Household Articles | 1 | 2012 | 24 | 0.110 |
Why?
|
Cadaver | 1 | 2016 | 1337 | 0.110 |
Why?
|
United States | 10 | 2021 | 69872 | 0.110 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 1993 | 295 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.100 |
Why?
|
Journal Impact Factor | 1 | 2013 | 156 | 0.100 |
Why?
|
Lipids | 2 | 2023 | 3305 | 0.100 |
Why?
|
Pancreas | 2 | 1998 | 1686 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 1995 | 424 | 0.100 |
Why?
|
Osteolysis | 1 | 1993 | 270 | 0.100 |
Why?
|
Child | 11 | 2018 | 77709 | 0.100 |
Why?
|
Minerals | 3 | 1989 | 275 | 0.100 |
Why?
|
Career Choice | 1 | 2018 | 744 | 0.100 |
Why?
|
Follow-Up Studies | 8 | 2015 | 39050 | 0.100 |
Why?
|
Antidiarrheals | 1 | 2011 | 45 | 0.100 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2015 | 547 | 0.100 |
Why?
|
Cost Savings | 1 | 2016 | 926 | 0.100 |
Why?
|
Pelvis | 1 | 1995 | 730 | 0.100 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2212 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 1999 | 1177 | 0.100 |
Why?
|
Choice Behavior | 1 | 2017 | 803 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1049 | 0.100 |
Why?
|
Triiodobenzoic Acids | 1 | 2011 | 124 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2000 | 1186 | 0.090 |
Why?
|
International Agencies | 1 | 2011 | 240 | 0.090 |
Why?
|
Wheelchairs | 2 | 1981 | 77 | 0.090 |
Why?
|
Capacity Building | 1 | 2013 | 248 | 0.090 |
Why?
|
Organ Specificity | 1 | 2015 | 2008 | 0.090 |
Why?
|
Endoscopy | 1 | 2000 | 1785 | 0.090 |
Why?
|
Iron | 2 | 1996 | 1774 | 0.090 |
Why?
|
Iopamidol | 1 | 2011 | 191 | 0.090 |
Why?
|
Electromagnetic Phenomena | 1 | 2011 | 161 | 0.090 |
Why?
|
Radiotherapy Dosage | 4 | 2010 | 2879 | 0.090 |
Why?
|
Anorexia Nervosa | 2 | 1989 | 1286 | 0.090 |
Why?
|
Chondroblastoma | 1 | 1990 | 50 | 0.090 |
Why?
|
Feces | 1 | 1995 | 1401 | 0.090 |
Why?
|
Work Simplification | 1 | 2008 | 7 | 0.090 |
Why?
|
Intestine, Small | 1 | 1995 | 1241 | 0.090 |
Why?
|
Emergency Service, Hospital | 6 | 2012 | 7659 | 0.090 |
Why?
|
Meglumine | 2 | 2000 | 149 | 0.090 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 245 | 0.080 |
Why?
|
Cholangiocarcinoma | 2 | 1995 | 516 | 0.080 |
Why?
|
Eosinophilic Granuloma | 1 | 1989 | 27 | 0.080 |
Why?
|
Survival Rate | 6 | 2008 | 12788 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 1996 | 1442 | 0.080 |
Why?
|
Benchmarking | 1 | 2015 | 1042 | 0.080 |
Why?
|
Quality Improvement | 3 | 2018 | 3749 | 0.080 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 160 | 0.080 |
Why?
|
Equipment and Supplies | 2 | 2002 | 281 | 0.080 |
Why?
|
Liver Abscess, Pyogenic | 1 | 2008 | 9 | 0.080 |
Why?
|
Ribs | 1 | 1990 | 252 | 0.080 |
Why?
|
Thoracoscopy | 1 | 2009 | 178 | 0.080 |
Why?
|
Maternal-Fetal Exchange | 1 | 2010 | 456 | 0.080 |
Why?
|
Diffusion of Innovation | 1 | 2013 | 725 | 0.080 |
Why?
|
Private Practice | 1 | 2008 | 154 | 0.080 |
Why?
|
Risk Factors | 7 | 2018 | 72290 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2016 | 9239 | 0.080 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2008 | 129 | 0.080 |
Why?
|
Relative Biological Effectiveness | 1 | 2009 | 323 | 0.080 |
Why?
|
Hip Prosthesis | 1 | 1993 | 917 | 0.070 |
Why?
|
Iodized Oil | 1 | 2006 | 10 | 0.070 |
Why?
|
Cohort Studies | 6 | 2015 | 40561 | 0.070 |
Why?
|
Tomography, Emission-Computed | 3 | 2010 | 1144 | 0.070 |
Why?
|
Time | 1 | 2008 | 542 | 0.070 |
Why?
|
Bone Diseases, Metabolic | 1 | 1991 | 417 | 0.070 |
Why?
|
Cryotherapy | 1 | 2007 | 155 | 0.070 |
Why?
|
Body Weight | 2 | 2016 | 4669 | 0.070 |
Why?
|
Laryngoscopy | 1 | 2012 | 711 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 1995 | 1513 | 0.070 |
Why?
|
Wrist Injuries | 1 | 1988 | 208 | 0.070 |
Why?
|
Organometallic Compounds | 2 | 2000 | 665 | 0.070 |
Why?
|
Angiography, Digital Subtraction | 2 | 2003 | 341 | 0.070 |
Why?
|
Young Adult | 5 | 2012 | 56430 | 0.060 |
Why?
|
Hemangioma | 4 | 2000 | 738 | 0.060 |
Why?
|
Thoracic Neoplasms | 1 | 2007 | 268 | 0.060 |
Why?
|
Ovarian Neoplasms | 2 | 2005 | 4838 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2008 | 1590 | 0.060 |
Why?
|
Phantoms, Imaging | 1 | 2013 | 2480 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1411 | 0.060 |
Why?
|
Job Satisfaction | 1 | 2008 | 535 | 0.060 |
Why?
|
Bone and Bones | 4 | 1994 | 2575 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3749 | 0.060 |
Why?
|
Ultrasonography, Prenatal | 2 | 2010 | 1695 | 0.060 |
Why?
|
Endoscopy, Digestive System | 1 | 2007 | 345 | 0.060 |
Why?
|
Cancer Care Facilities | 1 | 2007 | 402 | 0.060 |
Why?
|
Intracranial Aneurysm | 2 | 2003 | 1197 | 0.060 |
Why?
|
Adnexal Diseases | 1 | 2005 | 102 | 0.060 |
Why?
|
Data Collection | 1 | 2013 | 3341 | 0.060 |
Why?
|
Appendectomy | 1 | 2007 | 401 | 0.060 |
Why?
|
Neoplasms | 4 | 2012 | 21683 | 0.060 |
Why?
|
Hyperthermia, Induced | 1 | 2007 | 403 | 0.060 |
Why?
|
Patient Care Team | 1 | 2014 | 2531 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3068 | 0.060 |
Why?
|
Pandemics | 2 | 2020 | 8388 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2013 | 2266 | 0.060 |
Why?
|
Incidence | 3 | 2011 | 20947 | 0.060 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2008 | 1018 | 0.050 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2005 | 255 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.050 |
Why?
|
Radius Fractures | 1 | 1988 | 501 | 0.050 |
Why?
|
Ovariectomy | 1 | 2005 | 661 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2012 | 21746 | 0.050 |
Why?
|
Radiotherapy, Conformal | 1 | 2006 | 548 | 0.050 |
Why?
|
Bone Marrow | 3 | 1989 | 2948 | 0.050 |
Why?
|
Femur | 1 | 1989 | 1297 | 0.050 |
Why?
|
Abdomen, Acute | 1 | 2002 | 123 | 0.050 |
Why?
|
Kidney | 2 | 2015 | 7186 | 0.050 |
Why?
|
Time Factors | 5 | 2018 | 40075 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2007 | 2016 | 0.050 |
Why?
|
Prevalence | 2 | 2009 | 15226 | 0.050 |
Why?
|
Reoperation | 1 | 2011 | 4201 | 0.050 |
Why?
|
Duodenal Diseases | 1 | 2001 | 102 | 0.050 |
Why?
|
Neoplasm Staging | 3 | 2016 | 11031 | 0.050 |
Why?
|
Anticoagulants | 1 | 2016 | 4599 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2010 | 8642 | 0.050 |
Why?
|
Muscles | 2 | 1996 | 1614 | 0.050 |
Why?
|
Data Display | 1 | 2001 | 182 | 0.050 |
Why?
|
Adipose Tissue | 2 | 1989 | 3279 | 0.050 |
Why?
|
Guatemala | 1 | 2000 | 142 | 0.040 |
Why?
|
Gadolinium | 3 | 2000 | 952 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8089 | 0.040 |
Why?
|
Preoperative Care | 1 | 2008 | 2250 | 0.040 |
Why?
|
Heart Rate | 1 | 2011 | 4091 | 0.040 |
Why?
|
Transducers | 1 | 1980 | 252 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2007 | 2645 | 0.040 |
Why?
|
Quality Control | 1 | 2002 | 841 | 0.040 |
Why?
|
Costs and Cost Analysis | 2 | 2003 | 1681 | 0.040 |
Why?
|
Aldosterone | 1 | 2004 | 877 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3508 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4577 | 0.040 |
Why?
|
Consensus | 2 | 2022 | 2959 | 0.040 |
Why?
|
Duodenum | 1 | 2001 | 483 | 0.040 |
Why?
|
Gaucher Disease | 2 | 1989 | 112 | 0.040 |
Why?
|
Manganese | 2 | 1998 | 408 | 0.040 |
Why?
|
Deoxyglucose | 2 | 1997 | 337 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2013 | 3158 | 0.040 |
Why?
|
Ferrosoferric Oxide | 2 | 1996 | 360 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2005 | 20822 | 0.040 |
Why?
|
Technology Assessment, Biomedical | 1 | 1999 | 306 | 0.040 |
Why?
|
Pancreatic Pseudocyst | 1 | 1997 | 110 | 0.040 |
Why?
|
Education | 1 | 2020 | 543 | 0.040 |
Why?
|
Magnetite Nanoparticles | 2 | 1996 | 321 | 0.040 |
Why?
|
Intraoperative Care | 1 | 2000 | 767 | 0.040 |
Why?
|
Dextrans | 2 | 1996 | 595 | 0.040 |
Why?
|
Body Surface Area | 1 | 2016 | 198 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2007 | 6895 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6538 | 0.030 |
Why?
|
Cerebellum | 1 | 2003 | 1488 | 0.030 |
Why?
|
Bone Resorption | 2 | 1991 | 723 | 0.030 |
Why?
|
Pulmonary Veins | 1 | 2002 | 761 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5391 | 0.030 |
Why?
|
Pain | 3 | 2004 | 4986 | 0.030 |
Why?
|
Kidney Diseases, Cystic | 1 | 1997 | 186 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5137 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2006 | 2214 | 0.030 |
Why?
|
Adenoma, Liver Cell | 1 | 1995 | 33 | 0.030 |
Why?
|
Fluorine Radioisotopes | 2 | 1997 | 442 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 2016 | 143 | 0.030 |
Why?
|
Recurrence | 1 | 2007 | 8340 | 0.030 |
Why?
|
Prospective Studies | 8 | 2011 | 53288 | 0.030 |
Why?
|
Pancreatic Diseases | 1 | 1997 | 350 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2005 | 2795 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11124 | 0.030 |
Why?
|
Travel | 1 | 2000 | 788 | 0.030 |
Why?
|
Telecommunications | 1 | 1994 | 80 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 1995 | 520 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2008 | 15295 | 0.030 |
Why?
|
Cementation | 1 | 1993 | 91 | 0.030 |
Why?
|
Pelvic Neoplasms | 1 | 1995 | 254 | 0.030 |
Why?
|
Pancreatic Cyst | 1 | 1997 | 368 | 0.030 |
Why?
|
Foreign-Body Reaction | 1 | 1993 | 157 | 0.030 |
Why?
|
Acute Disease | 2 | 2003 | 7149 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 440 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1915 | 0.030 |
Why?
|
Body Height | 2 | 2016 | 1577 | 0.030 |
Why?
|
Truth Disclosure | 1 | 2016 | 436 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2007 | 6364 | 0.030 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1876 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2018 | 5078 | 0.020 |
Why?
|
Neck Injuries | 1 | 2012 | 152 | 0.020 |
Why?
|
Uterus | 1 | 1995 | 711 | 0.020 |
Why?
|
Mass Screening | 1 | 2007 | 5255 | 0.020 |
Why?
|
Cysts | 4 | 1997 | 678 | 0.020 |
Why?
|
Prognosis | 2 | 2004 | 29063 | 0.020 |
Why?
|
Cooking | 1 | 2012 | 313 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2006 | 4034 | 0.020 |
Why?
|
Fiducial Markers | 1 | 2011 | 136 | 0.020 |
Why?
|
Graft Survival | 1 | 2000 | 3737 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2011 | 683 | 0.020 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2011 | 145 | 0.020 |
Why?
|
Osteoma, Osteoid | 1 | 1990 | 80 | 0.020 |
Why?
|
Nail-Patella Syndrome | 1 | 1989 | 13 | 0.020 |
Why?
|
Abdominal Injuries | 1 | 2012 | 352 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3679 | 0.020 |
Why?
|
Spleen | 1 | 1995 | 2362 | 0.020 |
Why?
|
Methylene Blue | 1 | 2009 | 155 | 0.020 |
Why?
|
Parathyroidectomy | 1 | 2011 | 235 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2011 | 1420 | 0.020 |
Why?
|
Lung | 2 | 2005 | 9856 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 1993 | 1206 | 0.020 |
Why?
|
Aorta | 1 | 1996 | 2061 | 0.020 |
Why?
|
Treatment Failure | 1 | 1993 | 2618 | 0.020 |
Why?
|
Infant | 2 | 2007 | 35136 | 0.020 |
Why?
|
Endometriosis | 1 | 1995 | 839 | 0.020 |
Why?
|
Pressure | 2 | 1981 | 1203 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 1989 | 231 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2008 | 7181 | 0.020 |
Why?
|
Child, Preschool | 2 | 2007 | 41006 | 0.020 |
Why?
|
Hip Joint | 1 | 1993 | 1002 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1993 | 1173 | 0.020 |
Why?
|
Fibula | 1 | 1989 | 269 | 0.020 |
Why?
|
Spinal Puncture | 1 | 2008 | 281 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1184 | 0.020 |
Why?
|
Ankle Joint | 1 | 1990 | 411 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 1995 | 1353 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2010 | 2924 | 0.020 |
Why?
|
Chronic Disease | 1 | 2000 | 9146 | 0.020 |
Why?
|
Melanoma | 1 | 2004 | 5510 | 0.020 |
Why?
|
Elbow Joint | 1 | 1988 | 357 | 0.020 |
Why?
|
Ovarian Cysts | 1 | 2005 | 115 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10943 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2008 | 2031 | 0.010 |
Why?
|
ROC Curve | 3 | 1997 | 3527 | 0.010 |
Why?
|
Observation | 1 | 2005 | 312 | 0.010 |
Why?
|
Pancreatic Neoplasms | 2 | 1998 | 5256 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1995 | 2020 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7729 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 2003 | 112 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4687 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2000 | 15540 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2011 | 12026 | 0.010 |
Why?
|
Maternal Age | 1 | 2005 | 802 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1993 | 3474 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13284 | 0.010 |
Why?
|
Menopause | 1 | 1989 | 1626 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1989 | 1416 | 0.010 |
Why?
|
Buttocks | 1 | 1981 | 110 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2505 | 0.010 |
Why?
|
Mammography | 1 | 2010 | 2476 | 0.010 |
Why?
|
Osteoporosis | 1 | 1989 | 1580 | 0.010 |
Why?
|
Chelating Agents | 1 | 2000 | 380 | 0.010 |
Why?
|
Arteries | 1 | 2003 | 1119 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2006 | 3616 | 0.010 |
Why?
|
Bone Density | 1 | 1991 | 3468 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5952 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4042 | 0.010 |
Why?
|
Intestinal Diseases | 1 | 2002 | 530 | 0.010 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 1997 | 49 | 0.010 |
Why?
|
Pain Measurement | 1 | 2007 | 3420 | 0.010 |
Why?
|
Electrocardiography | 1 | 2011 | 6442 | 0.010 |
Why?
|
Cystadenoma, Serous | 1 | 1997 | 102 | 0.010 |
Why?
|
Gestational Age | 1 | 2005 | 3493 | 0.010 |
Why?
|
Radiology, Interventional | 1 | 2000 | 460 | 0.010 |
Why?
|
Adrenal Cortex | 1 | 1995 | 140 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3327 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1681 | 0.010 |
Why?
|
Hepatoblastoma | 1 | 1995 | 87 | 0.010 |
Why?
|
Fatty Liver | 1 | 2000 | 727 | 0.010 |
Why?
|
Mucins | 1 | 1997 | 564 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2002 | 1161 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13408 | 0.010 |
Why?
|
Brain | 1 | 1999 | 26385 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11366 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2002 | 2149 | 0.010 |
Why?
|
Aging | 1 | 1989 | 8664 | 0.010 |
Why?
|
Thyroid Diseases | 1 | 1993 | 379 | 0.010 |
Why?
|
Survival Analysis | 1 | 2003 | 10252 | 0.010 |
Why?
|
Talus | 1 | 1990 | 72 | 0.010 |
Why?
|
Neck | 1 | 1993 | 697 | 0.010 |
Why?
|
Osteoradionecrosis | 1 | 1989 | 49 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2716 | 0.010 |
Why?
|
Calcaneus | 1 | 1990 | 138 | 0.010 |
Why?
|
Plasmacytoma | 1 | 1989 | 183 | 0.010 |
Why?
|
Menarche | 1 | 1989 | 516 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1995 | 3760 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1995 | 4851 | 0.000 |
Why?
|
Spinal Diseases | 1 | 1989 | 538 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 2541 | 0.000 |
Why?
|
Absorptiometry, Photon | 1 | 1989 | 1725 | 0.000 |
Why?
|
Spinal Neoplasms | 1 | 1989 | 760 | 0.000 |
Why?
|
Reference Values | 1 | 1989 | 4982 | 0.000 |
Why?
|
Thyroid Neoplasms | 1 | 1993 | 2282 | 0.000 |
Why?
|
Lumbar Vertebrae | 1 | 1989 | 1848 | 0.000 |
Why?
|
Regression Analysis | 1 | 1989 | 6459 | 0.000 |
Why?
|
Medicare | 1 | 1995 | 6566 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1994 | 25625 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 1989 | 25043 | 0.000 |
Why?
|